| Protective effect of aprotinin against lung damage in patients undergoing CABG surgery. | |
| | |
MedLine Citation:
|
PMID: 16128368 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: We investigated the protective effects of aprotinin, administered in the pulmonary artery, on lung damage after cardiopulmonary bypass (CPB). METHODS: A total of 20 patients undergoing elective coronary artery bypass grafting operations was included in the study and divided into two groups. In the aprotinin group (study group) (n = 10) the drug was administered in the pulmonary artery (15,000 KIU/min) via the pulmonary artery catheter. The control group (n = 10) received only placebo. Blood gas measurements, respiratory function tests, malondialdehyde (MDA), nitric oxide (NO), C4 and leukocyte counts were determined as parameters. Blood samples were taken before and after cross clamping. Lung biopsies were taken before and after CPB. RESULTS: In the aprotinin group, forced expiratory volume (FEV1) and paCO2 values were better than in the control group. The postclamping MDA value in the study group was 20.6 +/- 8.7 etamol/ml and in the control group 37.5 +/- 9.6 etamol/ ml. The post clamping NO value in the study group was 261.9 micromol/l and in the control group 147.20 +/- 27.6 micromol/l. C4 levels were found to be better in the study group than in the control group: reduced levels of C4 were found to be statistically significant (study group postclamping: 12.98 +/- 2.63 mg/dl vs. control group 20.6 +/- 11.81 mg/dl). The increase in leukocyte count was found to be statistically significant (12.63 +/- 3.83 x 10(3) vs. 7.27 +/- 1.72 x 10(3). The difference between the preoperative and postoperative FEV1 in the control group was statistically significant. A statistically significant difference was found in the postoperative FEV1 in both groups. CONCLUSION: Aprotinin administered in the pulmonary artery during CPB had a protective effect against lung damage after open-heart surgery. |
| | |
Authors:
|
Mustafa Erdogan; Sedat Kalaycioglu; Erkan Iriz |
Related Documents
:
|
15236038 - Effects of alveolar hypoxia on pulmonary capillary beds. 3893888 - Effect of high-frequency positive-pressure ventilation on halothane ablation of hypoxic... 18696208 - Anomalous pulmonary vein detected using three-dimensional computed tomography in a pati... 19614598 - Angioplasticity in asthma. 15236038 - Effects of alveolar hypoxia on pulmonary capillary beds. 18451348 - Nascent aneurysm formation at the basilar terminus induced by hemodynamics. |
Publication Detail:
|
Type: Controlled Clinical Trial; Journal Article |
Journal Detail:
|
Title: Acta cardiologica Volume: 60 ISSN: 0001-5385 ISO Abbreviation: Acta Cardiol Publication Date: 2005 Aug |
Date Detail:
|
Created Date: 2005-08-30 Completed Date: 2006-02-16 Revised Date: 2009-06-11 |
Medline Journal Info:
|
Nlm Unique ID: 0370570 Medline TA: Acta Cardiol Country: Belgium |
Other Details:
|
Languages: eng Pagination: 367-72 Citation Subset: IM |
Affiliation:
|
Gazi University Faculty of Medicine, Cardiovascular Surgery Department, Ankara, Turkey. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aprotinin
/
administration & dosage,
therapeutic use* Biopsy Blood Gas Analysis Cardiopulmonary Bypass* / adverse effects Complement C3 / analysis Complement C4 / analysis Coronary Artery Bypass* Female Hemostatics / administration & dosage, therapeutic use Humans Infusions, Intra-Arterial Leukocyte Count Lung / pathology Male Malondialdehyde / blood Middle Aged Nitric Oxide / blood Pulmonary Artery Reperfusion Injury / prevention & control* Respiratory Distress Syndrome, Adult / prevention & control* Respiratory Function Tests Serine Proteinase Inhibitors / administration & dosage, therapeutic use* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Complement C3; 0/Complement C4; 0/Hemostatics; 0/Serine Proteinase Inhibitors; 10102-43-9/Nitric Oxide; 542-78-9/Malondialdehyde; 9087-70-1/Aprotinin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Procalcitonin, c-reactive protein and neopterin levels in patients with coronary atherosclerosis.
Next Document: Long-term combined therapy with losartan and an angiotensin-converting enzyme inhibitor improves fun...